Advanced search
Publication Cover
HIV Clinical Trials Volume 2, 2001 - Issue 5
Submit an article Journal homepage
40
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Long-Term Follow-Up of HIV-1–Infected Thai Patients Immunized with Remune Monotherapy

W. SukeepaisarncharoenKhon Kaen University HospitalKhon Kaen, Thailand
,
V. ChurdboonchartMahidol University, Bangkok, Thailand;Trinity Medical Group USA, California, USA
,
S. KulpradistBMA Medical College and Vajira Hospital, Bangkok, Thailand
,
B. Isarangkura Na AyudthyaPramonkutklao Hospital, Bangkok, Thailand
,
S. RugpaoChiang Mai UniversityChiang Mai, Thailand
,
V. ChandeyingPrince of Songkla UniversitySongkla, Thailand
,
W. SirawarapornMahidol University, Bangkok, Thailand
,
D. CarloThe Immune Response Corporation, California, USA
&
R.B. MossThe Immune Response Corporation, California, USA
 show all
Pages 391-398 | Published online: 02 Feb 2015

REFERENCES

  • Kroes ACM, Leedertse D, Spaan WJM. Access to treatment for HIV in developing countries. Lancet. 1998;353:153.
  • UK NGO AIDS Consortium Working Group on Access to Treatment for HIV in Developing Countries. Access to treatment for HIV in developing countries: Statement from an international seminar on access to treatment for HIV in developing countries. Lancet. 1998;352:1379–1380.
  • Amornkul PN, Tansuphasawadikul S, Limpakarnjanarat K, et al. Clinical disease associated with HIV subtype B and E among 2104 patients in Thailand. AIDS. 1999;13:1963–1969.
  • Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med. 1996;335(5):297–303.
  • Surasiengsunk S, Kiranandana S, Wongboonsin K, Garnett GP, Anderson RM, van Griensven GJ. Demographic im-pact of the HIV epidemic in Thailand. AIDS. 1998;12(7): 775–784.
  • Dore G, Brown T, Tarantola D, KaIdo JM. HIV and AIDS in the Asia and Pacific region-an epideomiological over-view. AIDS. 1998;12(suppl B):S1–S10.
  • Limsuwan A, Churdboonchart V, Moss RB, et al. Safety and immunogenicity of REMUNE in HIV-infected Thai sub-jects. Vaccine. 1998;16(2-3):142–149.
  • Churdboonchart V, Moss RB, Sirawaraporn W, et al. Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in Thailand. AIDS. 1998;12:1521–1527.
  • Churdboonchart V, Sakondhavat C, Kulpradist S, et al. A double-blind, adjuvant-controlled trial of human immuno-deficiency virus type 1 (HIV-1) immunogen (REMUNE) monotherapy in asymptomatic, HIV-1-infected Thai sub-jects with CD4-cell counts of >300. Clin Diagn Lab Immunol. 2000;7(5):728–733.
  • Prior CP, Gore R, Harter J, et al. Inactivation and purifica-tion of human immunodeficiency virus-1 as antigen for the treatment of HIV-1 infection. BioPharm. 1996;9:22–34.
  • Choi DJ, Dube S, Spicer TP, Slade HB, Jensen FC, Poiesz BJ. Sequence note: HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant. AIDS Res Hum Retro viruses. 1997;13(4):357–361.
  • Young NL, Ponglertnapakorn P, Shaffer N, et al. Clinical field site evaluation of the FACSCount for absolute CD3+, CD3+ CD4+, and CD3+ CD8+ cell count determinations in Thailand. Clin Diagn Lab ImmunoL 1997;(6):783–786.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.
  • Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S. Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg. 1991;44(5):481–493.
  • Kilmarx PH, Limpakarnjanarat K, Kaewkungwal J, et al. Disease progression and survival with human immuno-deficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis. 2000;181(5):1598–1606.
  • Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease, a review. J Infect Dis. 1992;165:352–363.
  • Day M. No more cocktails. New Scientist. 2000;16:7.
  • Moss RB. HIV-1 Therapeutic immunization. In: Proceed-ings of the 2001 Palm Springs Symposium on HIV/AIDS; 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.